Oragenics enters $10M ATM stock offering agreement with Dawson James

ORAGENICS INC

May sell up to $10M common shares at-the-market through Dawson James Securities.
Sales agent commission of 3.0% of gross proceeds; reimbursement up to $30,000.
Net proceeds to fund ONP-002 development and general corporate purposes.
Shares sold on NYSE American; no obligation to sell any shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.